EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Impacts of MicroRNA-483 on Human Diseases

Katy Matson, Aaron Macleod, Nirali Mehta iD, Ellie Sempek, Xiaoqing Tang

Non-Coding RNA · 28.06.2023 · 9 (4) · 37

DOI: 10.3390/ncrna9040037 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Non-Coding RNA, online erschienen am 28.06.2023. Verfasst von Katy Matson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Michigan Technological University, Houghton, MI 49931, USA. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MicroRNAs (miRNAs) are short non-coding RNA molecules that regulate gene expression by targeting specific messenger RNAs (mRNAs) in distinct cell types. This review provides a com-prehensive overview of the current understanding regarding the involvement of miR-483-5p and miR-483-3p in various physiological and pathological processes. Downregulation of miR-483-5p has been linked to numerous diseases, including type 2 diabetes, fatty liver disease, diabetic nephropathy, and neurological injury. Accumulating evidence indicates that miR-483-5p plays a crucial protective role in preserving cell function and viability by targeting specific transcripts. Notably, elevated levels of miR-483-5p in the bloodstream strongly correlate with metabolic risk factors and serve as promising diagnostic markers. Consequently, miR-483-5p represents an appealing biomarker for predicting the risk of developing diabetes and cardiovascular diseases and holds potential as a therapeutic target for intervention strategies. Conversely, miR-483-3p exhibits significant upregulation in diabetes and cardiovascular diseases and has been shown to induce cellular apoptosis and lipotoxicity across various cell types. However, some discrepancies regarding its precise function have been reported, underscoring the need for further investigation in this area.

Schlagwörter

Stichwörter der Autor:innen

biomarkerdiabetesmiR-483-3pmiR-483-5pmiRNAs

Autor:innen und Institutionen

  • Department of Biological Sciences, Michigan Technological University, Houghton, MI 49931, USA.

ORCID-Profile: Nirali Mehta

Förderung

  • NIDDK NIH HHS
  • NIH HHS
  • National Institutes of Health
  • King-Chavez-Parks Future Faculty Fellowship

Zitieren

APA

Matson, K., Macleod, A., Mehta, N., Sempek, E., & Tang, X. (2023). Impacts of MicroRNA-483 on Human Diseases. Non-Coding RNA, 9(4), 37. https://doi.org/10.3390/ncrna9040037

Vancouver

Matson K, Macleod A, Mehta N, Sempek E, Tang X. Impacts of MicroRNA-483 on Human Diseases. Non-Coding RNA. 2023;9(4):37. doi:10.3390/ncrna9040037

BibTeX
@article{Matson2023,
  author = {Matson, Katy and Macleod, Aaron and Mehta, Nirali and Sempek, Ellie and Tang, Xiaoqing},
  title = {Impacts of MicroRNA-483 on Human Diseases},
  journal = {Non-Coding RNA},
  year = {2023},
  volume = {9},
  number = {4},
  pages = {37},
  doi = {10.3390/ncrna9040037}
}
Kostenlos starten →